JP2017508737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508737A5 JP2017508737A5 JP2016552579A JP2016552579A JP2017508737A5 JP 2017508737 A5 JP2017508737 A5 JP 2017508737A5 JP 2016552579 A JP2016552579 A JP 2016552579A JP 2016552579 A JP2016552579 A JP 2016552579A JP 2017508737 A5 JP2017508737 A5 JP 2017508737A5
- Authority
- JP
- Japan
- Prior art keywords
- mcg
- csf
- days
- analog
- retinoid agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461941233P | 2014-02-18 | 2014-02-18 | |
| US61/941,233 | 2014-02-18 | ||
| PCT/US2015/016447 WO2015126989A1 (en) | 2014-02-18 | 2015-02-18 | Compositions and methods for treating neutropenia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017508737A JP2017508737A (ja) | 2017-03-30 |
| JP2017508737A5 true JP2017508737A5 (enExample) | 2018-03-29 |
Family
ID=53878925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552579A Pending JP2017508737A (ja) | 2014-02-18 | 2015-02-18 | 好中球減少症の治療用の組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10286039B2 (enExample) |
| EP (1) | EP3107533A4 (enExample) |
| JP (1) | JP2017508737A (enExample) |
| KR (1) | KR20160113302A (enExample) |
| CN (1) | CN106413701A (enExample) |
| AU (1) | AU2015219038B2 (enExample) |
| CA (1) | CA2937340C (enExample) |
| MX (1) | MX2016010699A (enExample) |
| RU (1) | RU2016136833A (enExample) |
| WO (1) | WO2015126989A1 (enExample) |
| ZA (1) | ZA201605109B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2858636B1 (en) | 2012-06-07 | 2018-09-05 | Childrens Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| CN107130026B (zh) * | 2017-05-15 | 2018-03-09 | 新疆医科大学第四附属医院 | 一种结直肠癌诊断和治疗效果评价相关的基因 |
| CN111886008B (zh) * | 2017-10-18 | 2024-05-31 | 港大科桥有限公司 | 用于抗mers-冠状病毒治疗的组合物和方法 |
| CN112390731B (zh) * | 2020-11-16 | 2022-11-25 | 成都大学 | 一种具有多靶点的维甲酸类衍生物及其制备方法与应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| CA2273288A1 (en) | 1996-12-19 | 1998-06-25 | James Joseph Gibbons | Method of treating or inhibiting neutropenia |
| AU9084601A (en) | 2000-09-08 | 2002-03-22 | Massachusetts Inst Technology | G-csf analog compositions and methods |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| AU2003902308A0 (en) | 2003-05-14 | 2003-05-29 | Diagnose It Pty Ltd | A method and system for the monitoring of medical conditions |
| WO2004100972A1 (ja) | 2003-05-16 | 2004-11-25 | Kyowa Hakko Kogyo Co., Ltd. | 組織破壊を伴う疾患の予防及び／または治療剤 |
| EP1621191A1 (en) | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| JP2008509928A (ja) | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| RS51506B (sr) | 2004-12-02 | 2011-06-30 | Venus Remedies Limited H. O&R&D. | Smeše za suzbijanje beta-laktamazom posredovane rezistencije na antibiotike upotrebom inhibitora beta-laktamaze, korisne za injekcije |
| WO2006071451A2 (en) | 2004-12-03 | 2006-07-06 | The Regents Of The University Of California | Compounds that prevent macrophage apoptosis and uses thereof |
| CN101472572B (zh) | 2006-05-16 | 2012-10-10 | Io治疗有限责任公司 | Rar拮抗剂或反向激动剂在治疗化学疗法和/或放射疗法副作用中的用途 |
| MX2009009997A (es) | 2007-03-30 | 2009-12-08 | Tmrc Co Ltd | Preparacion de la capsula de tamibarotene. |
| JP2011505386A (ja) | 2007-12-06 | 2011-02-24 | シーエスエル、リミテッド | 白血病性幹細胞の阻害方法 |
| US8580516B2 (en) * | 2008-09-05 | 2013-11-12 | University Of Chicago | Methods and compositions for direct detection of DNA damage |
| AU2010309388B2 (en) | 2009-10-19 | 2016-03-10 | Laila Nutraceuticals | Extracts, fractions and compositions comprising acetogenins and their applications |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) * | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| EP2847198B1 (en) | 2012-05-08 | 2016-12-14 | Lycera Corporation | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease |
| US20150147309A1 (en) | 2012-06-06 | 2015-05-28 | Fondazione Telethon | Allosteric chaperones and uses thereof |
| EP2858636B1 (en) | 2012-06-07 | 2018-09-05 | Childrens Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| US20160172942A1 (en) | 2013-07-04 | 2016-06-16 | Linak A/S | Actuator system |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
-
2015
- 2015-02-18 MX MX2016010699A patent/MX2016010699A/es unknown
- 2015-02-18 CA CA2937340A patent/CA2937340C/en active Active
- 2015-02-18 EP EP15751576.8A patent/EP3107533A4/en not_active Withdrawn
- 2015-02-18 WO PCT/US2015/016447 patent/WO2015126989A1/en not_active Ceased
- 2015-02-18 JP JP2016552579A patent/JP2017508737A/ja active Pending
- 2015-02-18 KR KR1020167025068A patent/KR20160113302A/ko not_active Withdrawn
- 2015-02-18 US US15/119,339 patent/US10286039B2/en active Active
- 2015-02-18 CN CN201580009151.6A patent/CN106413701A/zh active Pending
- 2015-02-18 AU AU2015219038A patent/AU2015219038B2/en not_active Ceased
- 2015-02-18 RU RU2016136833A patent/RU2016136833A/ru not_active Application Discontinuation
-
2016
- 2016-07-21 ZA ZA2016/05109A patent/ZA201605109B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527092A5 (enExample) | ||
| JP2019503365A5 (enExample) | ||
| JP2013533858A5 (enExample) | ||
| CN101636145A (zh) | 长期24小时经肠给予左旋多巴/卡比多巴 | |
| JP2014528474A5 (enExample) | ||
| JP2018520189A5 (enExample) | ||
| JP2011190199A (ja) | 関節リウマチ薬 | |
| IL292770A (en) | Formulations and dosages of polyethylene glycol-modified oricase | |
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| JP2023537921A5 (enExample) | ||
| RU2016136833A (ru) | Композиции и способы для лечения нейтропении | |
| JP2016505050A5 (enExample) | ||
| CN1913902A (zh) | 使用喹硫平抗精神病药物治疗精神疾病 | |
| JP2023531930A5 (enExample) | ||
| JP2023502053A5 (enExample) | ||
| CN1287855C (zh) | B型慢性肝炎治疗剂 | |
| JP2022526643A5 (enExample) | ||
| US8198293B2 (en) | Oxymatrine compositions and related methods for treating and preventing chronic infectious diseases | |
| JP2022518527A5 (enExample) | ||
| JP2021091608A5 (enExample) | ||
| JP2012031141A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| JP2015520759A5 (enExample) | ||
| JP2025521501A5 (enExample) | ||
| RU2013155476A (ru) | Композиции и способы изменения фенотипов xlhed |